Found: 19
Select item for more details and to access through your institution.
Usefulness of antiemetic therapy with aprepitant, palonosetron, and dexamethasone for lung cancer patients on cisplatin-based or carboplatin-based chemotherapy.
- Published in:
- Supportive Care in Cancer, 2015, v. 23, n. 1, p. 185, doi. 10.1007/s00520-014-2339-4
- By:
- Publication type:
- Article
Reversal of breast cancer resistance protein (BCRP/ABCG2)-mediated drug resistance by novobiocin, a coumermycin antibiotic.
- Published in:
- International Journal of Cancer, 2004, v. 108, n. 1, p. 146, doi. 10.1002/ijc.11528
- By:
- Publication type:
- Article
A Phase II Study of S-1 for Previously Untreated Elderly Patients with Advanced Non-Small Cell Lung Cancer.
- Published in:
- Chemotherapy (0009-3157), 2016, v. 61, n. 2, p. 93, doi. 10.1159/000441486
- By:
- Publication type:
- Article
AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-018-08074-0
- By:
- Publication type:
- Article
Different effects of telithromycin on MUC5AC production induced by human neutrophil peptide-1 or lipopolysaccharide in NCI-H292 cells compared with azithromycin and clarithromycin.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Erlotinib for Non‐Small Cell Lung Cancer with Leptomeningeal Metastases: A Phase II Study (LOGIK1101).
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1869, doi. 10.1634/theoncologist.2020-0640
- By:
- Publication type:
- Article
Methylation status of breast cancer resistance protein detected by methylation-specific polymerase chain reaction analysis is correlated inversely with its expression in drug-resistant lung cancer cells.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II study.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 7, p. 1972, doi. 10.1111/1759-7714.13490
- By:
- Publication type:
- Article
Phase II study of ramucirumab and docetaxel for previously treated non‐small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 2, p. 389, doi. 10.1111/1759-7714.13279
- By:
- Publication type:
- Article
Phase II study of nedaplatin and amrubicin as first‐line treatment for advanced squamous cell lung cancer.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 9, p. 1764, doi. 10.1111/1759-7714.13134
- By:
- Publication type:
- Article
Clinical and computed tomography characteristics of non‐small cell lung cancer with ALK gene rearrangement: Comparison with EGFR mutation and ALK/EGFR‐negative lung cancer.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 4, p. 872, doi. 10.1111/1759-7714.13017
- By:
- Publication type:
- Article
Phase II trial of a non‐platinum triplet for patients with advanced non‐small cell lung carcinoma (NSCLC) overexpressing ERCC1 messenger RNA.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 3, p. 452, doi. 10.1111/1759-7714.12958
- By:
- Publication type:
- Article
Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A1 * 28 or * 6 polymorphism: Results of the Lung Oncology Group in Kyushu ( LOGIK1004 A).
- Published in:
- Thoracic Cancer, 2017, v. 8, n. 1, p. 40, doi. 10.1111/1759-7714.12407
- By:
- Publication type:
- Article
Prospective study of the UGT1A1*27 gene polymorphism during irinotecan therapy in patients with lung cancer: Results of Lung Oncology Group in Kyusyu (LOGIK1004B).
- Published in:
- Thoracic Cancer, 2016, v. 7, n. 4, p. 467, doi. 10.1111/1759-7714.12360
- By:
- Publication type:
- Article
A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 3, p. 497, doi. 10.1007/s00280-014-2527-4
- By:
- Publication type:
- Article
BCRP/ABCG2 levels account for the resistance to topoisomerase I inhibitors and reversal effects by gefitinib in non-small cell lung cancer.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Serum progastrin-releasing peptide levels followed by whole-body positron emission tomography detects early recurrence of small-cell lung cancer.
- Published in:
- Respirology, 2007, v. 12, n. 1, p. 137, doi. 10.1111/j.1440-1843.2006.00966.x
- By:
- Publication type:
- Article
Adverse renal effects of anaplastic lymphoma kinase inhibitors and the response to alectinib of an ALK+ lung cancer patient with renal dysfunction.
- Published in:
- OncoTargets & Therapy, 2017, v. 10, p. 3211, doi. 10.2147/OTT.S136837
- By:
- Publication type:
- Article
Evaluation of a novel rapid TRC assay for the detection of influenza using nasopharyngeal swabs and gargle samples.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2021, v. 40, n. 8, p. 1743, doi. 10.1007/s10096-021-04193-7
- By:
- Publication type:
- Article